Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jian-An Pan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Frontiers in Cardiovascular Medicine|April 4, 2022
Initial Invasive or Conservative Strategy in Heart Failure With Preserved Ejection Fraction and Coronary Artery DiseaseJun Gu, Jian-An Pan, Jun-Feng Zhang, et al.
Anatolian Journal of Cardiology|November 2, 2019
Author's ReplyJun Gu, Zhao-Fang Yin, Jian-An Pan, et al.
International Journal of Cardiology|August 30, 2020
Characteristics, prognosis and treatment response in distinct phenogroups of heart failure with preserved ejection fractionJun Gu, Jian-An Pan, Hao Lin, et al.
Heart and Vessels|May 21, 2020
Association between long-term prescription of febuxostat and the progression of heart failure with preserved ejection fraction in patients with hypertension and asymptomatic hyperuricemiaJian-An Pan, Hao Lin, Chang-Qian Wang, et al.
Anatolian Journal of Cardiology|September 3, 2019
Visit-to-visit variability in low-density lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery diseaseJun Gu, Zhao-Fang Yin, Jian-An Pan, et al.
Internal Medicine Journal|August 4, 2020
Optimal management of blood glucose, blood pressure and atrial fibrillation to reduce the risk of heart failure with preserved ejection fractionLi Fan, Jian-An Pan, Hao Lin, et al.
The American Journal of the Medical Sciences|March 1, 2021
Association of Circulating Irisin Levels and the Characteristics and Prognosis of Coronary Artery DiseaseJian-An Pan, Hui Zhang, Quan Yu, et al.
Cardiovascular Diabetology|July 2, 2018
Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitusJun Gu, Jian-An Pan, Yu-Qi Fan, et al.
Cell Death & Disease|September 13, 2019
miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b/P53 pathway in doxorubicin-induced cardiotoxicityJian-An Pan, Yong Tang, Jian-Ying Yu, et al.
Oxidative Medicine and Cellular Longevity|September 6, 2021
MiR-21-3p Inhibits Adipose Browning by Targeting FGFR1 and Aggravates Atrial Fibrosis in DiabetesJian-An Pan, Hao Lin, Jian-Ying Yu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Cardiovascular Medicine|April 4, 2022
Initial Invasive or Conservative Strategy in Heart Failure With Preserved Ejection Fraction and Coronary Artery DiseaseJun Gu, Jian-An Pan, Jun-Feng Zhang, et al.
Anatolian Journal of Cardiology|November 2, 2019
Author's ReplyJun Gu, Zhao-Fang Yin, Jian-An Pan, et al.
International Journal of Cardiology|August 30, 2020
Characteristics, prognosis and treatment response in distinct phenogroups of heart failure with preserved ejection fractionJun Gu, Jian-An Pan, Hao Lin, et al.
Heart and Vessels|May 21, 2020
Association between long-term prescription of febuxostat and the progression of heart failure with preserved ejection fraction in patients with hypertension and asymptomatic hyperuricemiaJian-An Pan, Hao Lin, Chang-Qian Wang, et al.
Anatolian Journal of Cardiology|September 3, 2019
Visit-to-visit variability in low-density lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery diseaseJun Gu, Zhao-Fang Yin, Jian-An Pan, et al.
Internal Medicine Journal|August 4, 2020
Optimal management of blood glucose, blood pressure and atrial fibrillation to reduce the risk of heart failure with preserved ejection fractionLi Fan, Jian-An Pan, Hao Lin, et al.
The American Journal of the Medical Sciences|March 1, 2021
Association of Circulating Irisin Levels and the Characteristics and Prognosis of Coronary Artery DiseaseJian-An Pan, Hui Zhang, Quan Yu, et al.
Cardiovascular Diabetology|July 2, 2018
Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitusJun Gu, Jian-An Pan, Yu-Qi Fan, et al.
Cell Death & Disease|September 13, 2019
miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b/P53 pathway in doxorubicin-induced cardiotoxicityJian-An Pan, Yong Tang, Jian-Ying Yu, et al.
Oxidative Medicine and Cellular Longevity|September 6, 2021
MiR-21-3p Inhibits Adipose Browning by Targeting FGFR1 and Aggravates Atrial Fibrosis in DiabetesJian-An Pan, Hao Lin, Jian-Ying Yu, et al.
Pageof 2